i have thought about 5 times there has been a milestone reached that should have led to some share price appreciation. And each time the announcement made no difference. In the case of other biotechs the beginning of human trials has made a difference so “this time it is different”? Hope so. But the real movement is either when phase 3 starts and then again(more significantly) when efficiency readouts are positive. And both of those dates are not in 2023.
- Forums
- ASX - By Stock
- PYC
- The Attractions of PYC's pipeline
The Attractions of PYC's pipeline, page-24
Featured News
Add PYC (ASX) to my watchlist
(20min delay)
|
|||||
Last
19.0¢ |
Change
0.005(2.70%) |
Mkt cap ! $886.5M |
Open | High | Low | Value | Volume |
18.5¢ | 19.0¢ | 17.5¢ | $508.8K | 2.763M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 118941 | 18.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
19.0¢ | 183634 | 2 |
Last trade - 16.10pm 14/11/2024 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online